Premium
P3–268: Effect of body mass index on the efficacy, safety and tolerability of a higher‐dose 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease
Author(s) -
Sadowsky Carl,
Somogyi Monique,
Frolich Lutz,
Meng Xiangyi
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.1342
Subject(s) - tolerability , medicine , rivastigmine , adverse effect , body mass index , population , dementia , disease , donepezil , environmental health